3 hours Avadel Pharmaceuticals’ (AVDL) “Buy” Rating Reaffirmed at Needham & Company LLCMarketBeat
Needham & Company LLC restated a “buy” rating and set a $22.00 target price on shares of Avadel Pharmaceuticals in a research report on Friday.
XNeedham & Company LLC restated a “buy” rating and set a $22.00 target price on shares of Avadel Pharmaceuticals in a research report on Friday.
X